Skip to content

Exercise training in congenital heart disease: is it effective and safe and does it improve quality of life

Exercise training in congenital heart disease: is it effective and safe and does it improve quality of life - Exercisetraining and congenital heart disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37291
Enrollment
160
Registered
2009-04-14
Start date
2010-01-28
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease. heart defects

Interventions

Exercisetraining, 3 times a week, for 1 hour /training, aerobic level (target heart rate 60 % of maximal heartrate during exercise), for a 3 month period.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Surgical repair for Tetralogy of Fallot through transatrial-transpulmonary repair, below the age of 2 years, or - Surgical repair for single ventricle physiology, with intracardiac or extracardiac tunnel, performed before the age of 6 years as a (at least) 2-stage procedure (previous partial cavopulmonary repair), - Age at inclusion at least 10 years of age, - Being followed in Erasmus MC, LUMC, UMC St Radboud, UMCU Wilhelmina Children*s Hospital,

Exclusion criteria

Exclusion criteria: - Inability to exercise - Mental retardation - Standard contra-indications for MRI - Ventricular outflow obstruction (peak Doppler gradient > 60 mm Hg)

Design outcomes

Primary

MeasureTime frame
a) measures of aerobic fitness (all patients): oxygen uptake peak power in last half minute of graded bicycle ergometer test, b) measures of cardiac function; Fallot group: end-systolic right ventricle end-diastolic volume right ventricle ejection fraction of right ventricle end-systolic left ventricle end-diastolic volume left ventricle ejection fraction of left ventricle NT-proBNP level Fontan group: end-systolic single ventricle end-diastolic volume single ventricle ejection fraction of single ventricle NT-proBNP level c) measures of daily physical activity: percentage of day during which dynamic activities have been performed; average motility (as assessed by means of an Activity Monitor) d) health related quality of life, as assessed with questionnaires.

Secondary

MeasureTime frame
None

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)